Join the Irritable Bowel Syndrome group to help and get support from people like you.
Irritable Bowel Syndrome News (Page 2)
Related terms: IBS, Spastic colon
FDA Approves Xifaxan (rifaximin) for the Treatment of IBS-D (Irritable Bowel Syndrome with Diarrhea)
LAVAL, Quebec, May 27, 2015 /PRNewswire/ – Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) announced that its wholly owned subsidiary, Salix Pharmaceuticals, Inc., has received...
FDA Approves Viberzi (eluxadoline) for Irritable Bowel Syndrome with Diarrhea (IBS-D) in Adults
DUBLIN, May 27, 2015 /PRNewswire/ – Actavis plc (NYSE: ACT) announced today that Viberzi (eluxadoline) was approved by the Food and Drug Administration (FDA) as a twice-daily, oral treatment for...
FDA Approves Linzess to Treat Certain Cases of Irritable Bowel Syndrome and Constipation
August 30,2012 – The U.S. Food and Drug Administration today approved Linzess (linaclotide) to treat chronic idiopathic constipation and to treat irritable bowel syndrome with constipation (IBS-C)...
FDA Medwatch Alert: Zelnorm (tegaserod maleate)
[Posted 03/30/2007] FDA notified healthcare professionals and patients that Novartis has agreed to discontinue marketing Zelnorm, a drug used for the short-term treatment of women with irritable...
FDA Medwatch Alert: Zelnorm (tegaserod maleate)
The FDA and Novartis notified healthcare professionals of an important drug warning and prescribing information for Zelnorm, a serotonin 5-HT4 receptor partial agonist indicated for the short-term...
Further information
Related condition support groups
Related drug support groups
escitalopram, amitriptyline, venlafaxine, MiraLax, Linzess, nortriptyline, dicyclomine, Metamucil, Bentyl, view more... doxepin, Imodium, clomipramine, cholestyramine, Amitiza, Xifaxan, polyethylene glycol 3350